Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Outset Medical, Inc. updated its 2023 guidance (initiated).
- Period
- 2023
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
Outset expects 2023 revenue to be between $140 million to $150 million, growing approximately 22% to 30% over expected revenue for 2022. Non-GAAP gross margin is expected to expand to approximately 20% for the full year 2023 and exit the year in the mid-20% range for the fourth quarter of 2023.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Outset Medical, Inc. reported the fourth quarter and fiscal year ended December 31, 2022 results: revenue approximately $31.5 million.
- Period
- the fourth quarter and fiscal year ended December 31, 2022
- Revenue
- approximately $31.5 million
- Result
- preliminary results
Exact text from the filing
revenue for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter and Year End Highlights • Revenue in the fourth quarter is expected to be approximately $31.5 million, a 13% increase compared to $27.8 million in the third quarter of 2022 • Revenue for 2022 is expected to be approximately $115 million, a 12% increase compared to $102.6 million
View on SEC.gov